Skip to main content

Non-Small Cell Lung Cancer Topic Center

Interactive Features

videos


NSCLC, Oncology Coverage, Oncology Access
Videos
02/02/2026
Narjust Florez, MD
In this interview, Narjust Florez, MD, discusses how subcutaneous amivantamab from the PALOMA-3 study may improve patient experience, clinic workflow, and treatment adherence while highlighting ongoing unmet needs and real-world...
In this interview, Narjust Florez, MD, discusses how subcutaneous amivantamab from the PALOMA-3 study may improve patient experience, clinic workflow, and treatment adherence while highlighting ongoing unmet needs and real-world...
In this interview, Narjust...
02/02/2026
First Report Managed Care
Non-Small Cell Lung Cancer
Videos
01/27/2026
Corrine Stahura, PharmD, BCOP
Corrine Stahura, PharmD, BCOP, discusses how extended dosing intervals and subcutaneous formulations in non–small cell lung cancer are improving patient convenience, reducing infusion center burden, and enhancing operational efficiency while...
Corrine Stahura, PharmD, BCOP, discusses how extended dosing intervals and subcutaneous formulations in non–small cell lung cancer are improving patient convenience, reducing infusion center burden, and enhancing operational efficiency while...
Corrine Stahura, PharmD, BCOP,...
01/27/2026
First Report Managed Care
Non-Small Cell Lung Cancer
Videos
01/27/2026
Rajat Thawani, MD
Dr Rajat Thawani discusses how biomarker-driven strategies, emerging immunotherapies, and novel delivery approaches are rapidly redefining first-line non-small cell lung cancer (NSCLC) treatment—shifting care beyond traditional chemotherapy...
Dr Rajat Thawani discusses how biomarker-driven strategies, emerging immunotherapies, and novel delivery approaches are rapidly redefining first-line non-small cell lung cancer (NSCLC) treatment—shifting care beyond traditional chemotherapy...
Dr Rajat Thawani discusses how...
01/27/2026
First Report Managed Care
Non-Small Cell Lung Cancer
Videos
01/27/2026
Estelamari Rodriguez, MD, MPH
As new subcutaneous and targeted therapies enter the NSCLC landscape, the true cost of care extends far beyond drug price alone. In this interview, Estelamari Rodriguez, MD, MPH, a thoracic oncologist at Sylvester Comprehensive Cancer Center,...
As new subcutaneous and targeted therapies enter the NSCLC landscape, the true cost of care extends far beyond drug price alone. In this interview, Estelamari Rodriguez, MD, MPH, a thoracic oncologist at Sylvester Comprehensive Cancer Center,...
As new subcutaneous and targeted...
01/27/2026
First Report Managed Care
Hsu Headshot
Videos
07/11/2025
Melinda Hsu, MD
Dr. Melinda Hsu, thoracic oncologist and cancer survivorship director at UH Simon Cancer Center, shares insights on the evolving landscape of non–small cell lung cancer—highlighting challenges in early detection, treatment tolerability, and...
Dr. Melinda Hsu, thoracic oncologist and cancer survivorship director at UH Simon Cancer Center, shares insights on the evolving landscape of non–small cell lung cancer—highlighting challenges in early detection, treatment tolerability, and...
Dr. Melinda Hsu, thoracic...
07/11/2025
First Report Managed Care
Rodriguez Headshot
Videos
07/11/2025
Estelamari Rodriguez, MD, MPH
Dr. Estelamari Rodriguez, clinical research lead for thoracic oncology at the University of Miami Sylvester Cancer Center, explores how early biomarker testing, equitable access, artificial intelligence (AI)-driven data integration, and...
Dr. Estelamari Rodriguez, clinical research lead for thoracic oncology at the University of Miami Sylvester Cancer Center, explores how early biomarker testing, equitable access, artificial intelligence (AI)-driven data integration, and...
Dr. Estelamari Rodriguez,...
07/11/2025
First Report Managed Care
Thawani
Videos
07/11/2025
Rajat Thawani, MD
Dr. Rajat Thawani, a thoracic oncologist at OHSU Knight Cancer Institute, discusses groundbreaking advances in lung cancer treatment—highlighting the promise of antibody-drug conjugates (ADCs), the critical role of biomarker testing, and the...
Dr. Rajat Thawani, a thoracic oncologist at OHSU Knight Cancer Institute, discusses groundbreaking advances in lung cancer treatment—highlighting the promise of antibody-drug conjugates (ADCs), the critical role of biomarker testing, and the...
Dr. Rajat Thawani, a thoracic...
07/11/2025
First Report Managed Care
Alexander Spira, MD, PhD
Videos
09/26/2024
Alexander Spira, MD, PhD
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
09/25/2024
Martin Dietrich, MD, PhD
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Videos
06/18/2020
Roy S Herbst, MD, PhD, ensign professor of medicine and professor of pharmacology, chief of medical oncology, Yale Cancer Center and Smilow Cancer Hospital, discusses the results of the ADAURA study that examined the use of Tagrisso...
Roy S Herbst, MD, PhD, ensign professor of medicine and professor of pharmacology, chief of medical oncology, Yale Cancer Center and Smilow Cancer Hospital, discusses the results of the ADAURA study that examined the use of Tagrisso...
Roy S Herbst, MD, PhD, ensign...
06/18/2020
First Report Managed Care